- Report
- April 2024
- 120 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- February 2024
- 130 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- October 2023
- 120 Pages
Global
From €5709EUR$5,950USD£4,937GBP
- Report
- September 2023
- 208 Pages
Global
From €4006EUR$4,175USD£3,464GBP
- Report
- May 2024
- 299 Pages
Global
From €5229EUR$5,450USD£4,522GBP
- Report
- May 2024
- 92 Pages
Global
From €5373EUR$5,600USD£4,646GBP
- Report
- November 2023
- 146 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- November 2023
- 149 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- December 2023
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- December 2023
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- April 2024
- 135 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- October 2023
- 143 Pages
Global
From €2398EUR$2,499USD£2,073GBP
- Report
- November 2023
- 150 Pages
Global
From €4654EUR$4,850USD£4,024GBP
- Report
- February 2024
- 185 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 179 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 180 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- November 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 114 Pages
Global
From €4558EUR$4,750USD£3,941GBP
The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more